{"fieldsOfStudy":["Mathematics","Medicine"],"year":2010,"outCitations":["55bcd7dc9acd4bbd2b52c5af4d84f985605ccc95","227b2a23b7f29bb4c12f26bd622cc4e6a3e3274e","9a21cdea39ee58ce415cece3bd0780210b77d106","fb832743880bfa2acd49c65b9c329d9cea2b4ddc","812a72df9b6ece5a07eebdb299772677da5c663a","e54fdd22ca9d6c1094db3c0de18b3f184734dd23","75ca252b6c7226f0ff978b3c695f200748fb0536","391cef3f7d19d9e50cc07e2a0bdaa03f06268ec6","def3254e7bd0b165b7f4ec187fd250ddeaaf6b65","f169d03d8db5b10c995deb1df016d8b2e201f61a","a544bdfbb6c8aacfa064c7144e4cadae3fedcb61","54c18cf87996cb442131586f4079dcf408972920","040cf85e53e48aab1512ed8dd02d994eea0e4bcc","21154102098270f7e68d262319f144588ebd2448","f88ed7f4c305cfd970ca0cc11688c0fe960651d2","3d50343bb943f339f43eb541197475c8a8daae89","c66db9b93d75c0ff52e7f84605b8389345307006","fb8f9ec983d51b616513cf27664c068d59fa9ef2","dcfc7e798ff226d0271d8b8592d8e4a13ef59ac9","166c42895882039e4252f7c943efa13d0505109f","93e5501448c45e2002a44810b154efa5ad01cc9a","944006623073b2ea016b1040c64a74e857974bfc","e127ac7b2fe62455ce44dc014f9db29812f77cdf","efec641a203ffc7a49317962d09c974e751dbbb0","be10383254e0678068e34944bf2146fc9eb0e356","c1afad05c1ed9ca2cc5d63128b236a88d0097695"],"journalName":"The International Journal of Biostatistics","paperAbstract":"We consider the problem of constructing confidence intervals for the mean of a Negative Binomial random variable based upon sampled data. When the sample size is large, it is a common practice to rely upon a Normal distribution approximation to construct these intervals. However, we demonstrate that the sample mean of highly dispersed Negative Binomials exhibits a slow convergence in distribution to the Normal as a function of the sample size. As a result, standard techniques (such as the Normal approximation and bootstrap) will construct confidence intervals for the mean that are typically too narrow and significantly undercover at small sample sizes or high dispersions. To address this problem, we propose techniques based upon Bernstein's inequality or the Gamma and Chi Square distributions as alternatives to the standard methods. We investigate the impact of imposing a heuristic assumption of boundedness on the data as a means of improving the Bernstein method. Furthermore, we propose a ratio statistic relating the Negative Binomial's parameters that can be used to ascertain the applicability of the Chi Square method and to provide guidelines on evaluating the length of all proposed methods. We compare the proposed methods to the standard techniques in a variety of simulation experiments and consider data arising in the serial analysis of gene expression and traffic flow in a communications network.","inCitations":["f42f3a9e08f6216b9383a56c156ff363ee19d3b6","b67662134f0133ab61d89150561e2235c5ed15b9","1cb520a544bb09b4060ae851dbf42ed4c1a10d3e","e32e67f5e1caa8049723e7d12171109826fa29ac","59bcf47f1de7b684a20bb69b4e9dadfb8d6ee235","3f98b99d6ecfc644e32caf84d8878ae9096a7de8","84a2eb4c4cc59bca81d2d851eca3814abd476d8d","64f8218c9e77e06780c8843d6e19767249823d98","5882d21a92e13e9406e70df0b75904a4f15b9a67","9162cad6d96104dd290ac92c94209521baf98bd7","e995a26fa47fa2262fad40ca7ee10651938646e9","556387798b61afc9fbe286be1f3bf57e777e1e6f"],"title":"Confidence Intervals for Negative Binomial Random Variables of High Dispersion","doi":"10.2202/1557-4679.1164"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":2016,"outCitations":["c974243514e9b1a29950ccd776ba647ec3984a0f","5f4968dba41296ea83c8f9e473a69019f142a0ac","6856ae96a2ea4659907cdffff7e2dc451cb3307f","7319e8ae43a623062f557947156e58f88100d0dd","38346b01d8e077871a72005b67e4913fec4b30e9","7fa99444d4add37377c2f4c02d2517c5e056d57b","01c5bf5e1347734e31b2b745d095b1a576b75b80","2ea5eea143e8c8950cc108690841e506c358da39","67a16e52b525a18c08b3bbdf7ae243a7f5854475","cff6b9ae57ee4572f442b716a8dce2e67d84e7ff","f4e31b720ff5ae0e6a2d5e58353568d29664c3fa","bc9b8023d0a7f881c0dd29f7e206f3fc6c28669e","8ddca50774c09bdae74b49dac71b2b31563b1bda","fbb11a841893d4b68fa2173226285ded4f7b04d6","fb7f35ba81fa60745d9f112f1188f8a83caeaf23","3b139c3bf30f93456daba69ad408f1ff63686d6c","5c97720abb67a0d1c8b566abefc4ffdd95ebf331","a16cf19b4adc5ff21a5477be0637359331135f0a","09960af94bcbc64ccc65704f3e31695731c02623","66de59f711a865437f81fa66c8914a222e8f2979","0421e03b6803390af01d3f12cba14a4973121f9f","03c0b4aeb0cded04fdca7d5b96193249b831e394","64cfe8dfe1641bc588d6813f9e6a223214064f36","4ce8c298fc8d38fd96f6c6cb72e9d8d53caec3da","665e803556fce875d20e4877ba553c6438be70ed","b26eb5cca8f7a72276be76dbc0e5d2f09ad0e94f","bd21a93e3631bfd0617db727a9aa980d5018da3d","6bb0bb25d2a4ea1ad98ada3014f92b705e28aaec","bc86dbc0adbaa9d8b847ab1b14f303cf4249aeda","8392ee0cb73c29b625e61fa1c8a272d6111ad8d6","b062fb0b241c65a6f1033dea8f994ec6e01d4740","2046a5a643a2757d9ba2e88f96b1e5b4b8c4ca6f","ee2cd1d17f833d3c157a1016a778c7c22af555a2","e45b74bf3ede47ff25dee775800d16cfdf01cfdc","154aa9d3a0047be065bf28672551728a14ec0d43","e02d1d482ea7a51ede5a0babd45ab3d4344a8e13","fd870cc95cb72d6c64a6a49400dc5ec93a0acbb1","601377b63c6a3af80d3ee063fc370423759affd7","98466c81c667c8933df78ec651e17e96ee0b39f4","101f7a939979e4c635569286f889e48ab869298a","5f3bc8c105d10ad178b7ca7ed3c30eb197c11d80","1bcceab8457104047d9636a2d6ca9eabf6d895bc","23aa024436def0b34b56b1f0213f4257e68c0f94","7ed1526b9bc7d012d7e2b01f415fda496bf372b4","5a111f700157140b3958fc3b8b4580a09741a9ef","50857af657dcf6cfc54150afa7b40a3bec06aa85","6673b0aefae40ce236bd8568e4e1a1483d27df46","8c6fe027f5ca89b37b3dd5ddf295ce99f9fa19cc","5fb18ef595c525f62e03028179e3b83142dcab6e","52b4938b31d1f5f4d95a9f37d688cd3ac12c2027","3e1737b3be4d38cb773fd1866d085adba895e336","f75335de63175de16bca22505bad44d3cbd7a42f","e6e4e387981b7ff301f582a48b33a316e99a293d","534a40a659eab682dada79b15d97e772441aee66","053bff737b7a5530546af87bb0f3f1dda253a11f","6be6cfd6039cc066fe8d3d39e9af6da84f00d482","d900514af28458b8acb0735ef2e988cd261e691b","04230cb71de244145e1ecbe43e235e48d04c4317","af6fb9f1eb8a69ec681ea7e9e1a0302679aff349","4a9253b78713c30fb350d56c3fd4b1c589452fce","998a2620d6aa2d5c256cc107a500ad701331b67b","2c043af955d9b2e8f56723216d6b0a99b8cc4441","68a08f57ce967aa8a13f63b41bff953da54ded8c","f1df469dd8ef9f0a9ff2102142df3068d67e21be","6415e50572010e1f0773481c873227640944c0a0","bf15d535300a4d711720bce1f614f6df6cf12c56","89cc795f4d213164401ba1d21c3fb029d422d981","f1b3de8be3c265bfbafb35ac515f74919cce7c60","e8135772a3f2b29baad890eb20b7dd85f7064e78","164e1c0ca7fdb0e6ef1441101e81f28f84036631","516ed05ff3d97707d7dab3c2eae697840946bd80","f1302f767b52df0d4e2b488334a8b3684e4d0bf2","754f2c6e22dd5f80f55c4a14a7743f1638e2978b","dfb30e03e4c8f7604842aea50da53801be82a75d","a706fca8b3163a74da5fc9cd005287a5e42b1547","41f6a8ed8110928b7f7304c2a84b0ae1bf81fdf4","6531bc08830d0c63e5c0c235e0ee21d17f15afad","b6d0906ba50119fca2843b84ded50ed63eefa6ae","c54a91266b45a31ad2cad3f71a0e4072748c7bd1","70e45316b97b67b0d43d65d8da7073aad1514f13","ee105410690ebdbd7456a0293220cc7372c4514e","84dcd8d1e4eba49d0182022a66c7e33394bca2f9","f55dd93b371e8590e055cf71731af5513eae9028","7a6d869e8e0a35bbab97fda15fef29af9404d2f7","8a51227423a40632743592e7d4912094c6341a15","e2a5ccb2e01512c7176174906cffd80cf5f6a0da","db0bafe6cb27ea6a0843e2c41346aba29d9fb992","d7e5e4c081d1856c4aa8f0df62561eb51be355a9","1f3679c06b95680c8fc0f8c7d9419e8b95a1864a","a3fbbbbf897adc209d3783147e9f91302b292f7e","91508210e7bb44c1e53676a75906a9b4049fcaff","6269e7c4a211b49ccd26781844264baf34f04f5b","321239134646738bd4b3bf217f271794874c6a75","4e1f60a5de6aa0689c84023ac15ef8d6777222ba","6e0ead3c524293146f2d9c1c9fa3330db7febcaa","c09b8ef54cf69bbff190f5634b4799f08edbc8c7","d40fee01a7708099f9e9392f10ac0b370b7ed8a8","db33c10eefd66d395e3cc85e95420c701c508e18","facc67345a10e57c32430c4be7cf22d108a694ce","d119b19bcf249796684222d610205de53c2c875a"],"journalName":"Pharmaceutical statistics","paperAbstract":"The use of Bayesian approaches in the regulated world of pharmaceutical drug development has not been without its difficulties or its critics. The recent Food and Drug Administration regulatory guidance on the use of Bayesian approaches in device submissions has mandated an investigation into the operating characteristics of Bayesian approaches and has suggested how to make adjustments in order that the proposed approaches are in a sense calibrated. In this paper, I present examples of frequentist calibration of Bayesian procedures and argue that we need not necessarily aim for perfect calibration but should be allowed to use procedures, which are well-calibrated, a position supported by the guidance.","inCitations":["c9c48cfbda15232793e585fd7c9a84c13dac0904","3b31eba04973fe8d27e48b0d3fde1fa0ccff1eb0","38b59256b6ee84974f460a0f86330417bb512ae1","ced059b36898d7a0ade70cd5e1d24d11a95dc423","2e5d0547c61286075560d979985ecf50d3e7bce2","2149635c8d3a7589260c1960f703b013c3b45fd0"],"title":"Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.","doi":"10.1002/pst.1736"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2018,"outCitations":["464ac8ef90353bbdb36aa2d6ecadb9104b458b9a"],"journalName":"Biostatistics","paperAbstract":"Many populations of early-stage cancer patients have non-negligible latent cure fractions that can be modeled using transformation cure models. However, there is a lack of statistical metrics to evaluate prognostic utility of biomarkers in this context due to the challenges associated with unknown cure status and heavy censorship. In this article, we develop general concordance measures as evaluation metrics for the discriminatory accuracy of transformation cure models including the so-called promotion time cure models and mixture cure models. We introduce explicit formulas for the consistent estimates of the concordance measures, and show that their asymptotically normal distributions do not depend on the unknown censoring distribution. The estimates work for both parametric and semiparametric transformation models as well as transformation cure models. Numerical feasibility of the estimates and their robustness to the censoring distributions are illustrated via simulation studies and demonstrated using a melanoma data set.","inCitations":["e52f17cffd6e502146b7f415d251af4f02bb636c","8433fd5ee37b9e7665130b512df5e10ccf2fc36f"],"title":"Concordance measure and discriminatory accuracy in transformation cure models.","doi":"10.1093/biostatistics/kxx016"}
{"fieldsOfStudy":["Computer Science","Medicine","Mathematics"],"year":2017,"outCitations":["9e583802eeec570453931b7a25c3f0acfe0849a5","a3fe2fb7ccb0c427a25fec8159996c674e299c68","895217d527de919dfdfbfeae5362bf5adba984ce","6db548bfd2a87297d01478abe86e69a6e7520b3d","d98ef875e2cbde3e2cc8fad521e3cbfe1bddbd69","f8342f184985f75b8f903ee45b2d4d87a9469789","b0cdd840ab8ac9717a8dc69e05c8bd1eb41256e0","79e8b756f8cc59b4b5aaf1a7de7094f3a935803e","6ed0e4a022dbc09ed1e0748a4ba8c192f5dd1d90","4d1ce1c69fdf6fd2ba4ec81ce7f0a6df49c6eba9","d6e477e034b0edd0ba217f8f83c0703f08cd3871","40657db7416fef90250d332513f0092a5a9ee848","009acdc4da6a67185cab82dcad4fdbc3e9becbf9","5816e81bb0a91485a09fbfe392d764c132328b16","57cca95fdbd35ba1b283c9c6ec5ae7a81be7adfd","b5f109c8d49a95f72313aff41cf8a0b2e8e1407a","67f33b4ea84c8cf815a9919dd34fee6e85c22f6f","8dfeab3c1ba9150c726318b73de2a126b0e0f437","e2bff19225be31650c4f54c17d36c6317237dd2a","f7b488cd9377e2b1b47b70b7bb32155066917ece","3448bc23b911ab7446d3384422cd4db8d6ddf111","156e7730b8ba8a08ec97eb6c2eaaf2124ed0ce6e","000551662c3902ed66709be879053d95dafc0211","9409f5a5a793b9ff0e2582f24d5d10ade008ae2a","e829ab6b80ea65febb23264e44711e51304b1ed3","0275a62863912b77b01c455d7e2eaa33656b2166","b5622ba24a8a2f5ed1e67c5f294476db0423ad35","5f56320c5979faeab78dbd9ddb7db755ba4550f3","c93060355830534d0c146fbd3005e7391406aaad","97794d424f5e7cc555f6aeb187ab0849976dbeac","418ca74964d4c9ceba96fe2d7183f62858bdada9","0370e445c48955ebd893df71f2184e7870bb731c","9c445e726cb8ca9c05312f9642c2129d8396d71b","df2918f76db4503ab89d4e89af22fe2c96531d53","998cd223e507ab83c9d1bbf2dfca008bc6e36c8e","a32c1089581ad7acf69576e52ce1b388192542f9","1b60c4fddb8ab5475bc3295a2d0af4b1167bc444","47e0eca9f722167c3ec1e9f0ad5d48c81e83d1f8","b365b8e45b7d81f081de44ac8f9eadf9144f3ca5","fcef2258a963f3d3984a486185ddc4349c43aa35","ecf9e1564767c19d37dccf1aae5515281e3e0ad8","dc81b0c3970c2940a26f4d3cdc640fe7e8a45ae6","ed29ed4d70944589a6826ba99bfccbfb322cb775","c8430c5d13834e46631960469d86f7ed4577b0e2","ce3ccde80ccaaa2225b6f495130aefb2cf436e18"],"journalName":"The annals of applied statistics","paperAbstract":"We tackle the problem of selecting from among a large number of variables those that are \"important\" for an outcome. We consider situations where groups of variables are also of interest. For example, each variable might be a genetic polymorphism, and we might want to study how a trait depends on variability in genes, segments of DNA that typically contain multiple such polymorphisms. In this context, to discover that a variable is relevant for the outcome implies discovering that the larger entity it represents is also important. To guarantee meaningful results with high chance of replicability, we suggest controlling the rate of false discoveries for findings at the level of individual variables and at the level of groups. Building on the knockoff construction of Barber and Cand√®s [Ann. Statist. 43 (2015) 2055-2085] and the multilayer testing framework of Barber and Ramdas [J. Roy. Statist. Soc. Ser. B 79 (2017) 1247-1268], we introduce the multilayer knockoff filter (MKF). We prove that MKF simultaneously controls the FDR at each resolution and use simulations to show that it incurs little power loss compared to methods that provide guarantees only for the discoveries of individual variables. We apply MKF to analyze a genetic dataset and find that it successfully reduces the number of false gene discoveries without a significant reduction in power.","inCitations":["04b3f0108b0edbcd4905f57a8a813ffdd2e9b4ba","a3aae676ecf4dc82d3e84525ebc8aae226ce6992","51a136885660243648355f8372598027ccefd1c5","6bba817804b350037fcee15dd4d5c2f31b7d6c1d","6f7421d24b2017d7e1242f74b9a5109fe90b9d8c","afc8c291aa589389e6c86407c16a5a646daddaaf","24f8a55cf794d6a0d1c4a90720eff705d5eb3548","7e504bfb29d24a97e374b90c0f9ce4bdf1bcc68b","ed6606260eb60c87edf1044c3e1c2b06c0afd5d4","30875fc5e6a4972d16936d5235e84966d8cf3a81","deed3db4ac71a6dc1cf6f5d965e8c5d0e88f64f4","a9457a06fb1838e9c250ed2b5b7adcc37f57264c","28b29ba8db35f001b33240676e3093f8cc73c27f","2396ec6250ca41bc88b9fd3b47ef1a5faa917b59"],"title":"Multilayer Knockoff Filter: Controlled Variable Selection at Multiple Resolutions.","doi":"10.1214/18-AOAS1185"}
{"fieldsOfStudy":["Computer Science","Mathematics","Medicine"],"year":2010,"outCitations":["96d65cdff40ef1bd8e64fbaff48bc17c4cf509bd","9679e8c3c34e8666135409c34bae2f2b8debf8f4","18547b1c922dca13211a85ab7d3f32cd632a12d1","90394d8e02524678d491362f362f2ccdb12cf1b8","ce8a716e369245c33d9ac91506fd2a0300496fe4","37e44d1de8003d8394d158ec6afd1ff0e87e595b","e1b3e4647471837133839eab496b4a5a3df64415","0b6bbeb0731cac1783db6bdff34eec683851bf19","30e7e25061b7ccd9a625548dd6836afcff85043b","f44121e29e68131ce988968cf0a1ca51a8f170c3","c3fa8a4b90d7c245839a1369fc46382ee257d6d3","9c5d664e277ea475f6953521fd2783f99f61cf1c","e0829acad800ce0e98c1745d11607c5bed8c8a14","c28c2984f7f6e97596034f5e0ad1b85500f4b223","8ae7eee903493f85645f0574ca1384c3c9cc719e"],"journalName":"Computational statistics & data analysis","paperAbstract":"Fluorescence spectroscopy has emerged in recent years as an effective way to detect cervical cancer. Investigation of the data preprocessing stage uncovered a need for a robust smoothing to extract the signal from the noise. Various robust smoothing methods for estimating fluorescence emission spectra are compared and data driven methods for the selection of smoothing parameter are suggested. The methods currently implemented in R for smoothing parameter selection proved to be unsatisfactory, and a computationally efficient procedure that approximates robust leave-one-out cross validation is presented.","inCitations":["601fc8a1379edd2efaa07b2159e9bf3ab439953f","6503c05864240b7396aa2a4fc3036504b704d330","3e6ae5d1e8ab308ff7254b9ba71a16f543f50de0","ff14a7110e863be313714a270e5855febfd50d3a","82cf99457ab9180d1f44c732ed4fd7f9818643eb","f5263dd4508cc24c44362e6bbf84d84544125779","fa70019e6a1afd46f8979d3684fa53e52b436b6c","f8d52bd18bae466ef71ecacd4bc85dc90d09143c","d7c0b7e8a2dacc9fef147ed4a60c07bdbd99901e"],"title":"Robust smoothing: Smoothing parameter selection and applications to fluorescence spectroscopy","doi":"10.1016/j.csda.2009.08.001"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":2016,"outCitations":[],"journalName":"Communications for statistical applications and methods","paperAbstract":"Causal inference methodologies have been developed for the past decade to estimate the unconfounded effect of an exposure under several key assumptions. These assumptions include, but are not limited to, the stable unit treatment value assumption, the strong ignorability of treatment assignment assumption, and the assumption that propensity scores be bounded away from zero and one (the positivity assumption). Of these assumptions, the first two have received much attention in the literature. Yet the positivity assumption has been recently discussed in only a few papers. Propensity scores of zero or one are indicative of deterministic exposure so that causal effects cannot be defined for these subjects. Therefore, these subjects need to be removed because no comparable comparison groups can be found for such subjects. In this paper, using currently available causal inference methods, we evaluate the effect of arbitrary cutoffs in the distribution of propensity scores and the impact of those decisions on bias and efficiency. We propose a tree-based method that performs well in terms of bias reduction when the definition of positivity is based on a single confounder. This tree-based method can be easily implemented using the statistical software program, R. R code for the studies is available online.","inCitations":["5190fdd5cd9163316084838cbcd8916facb617b3"],"title":"Practice of causal inference with the propensity of being zero or one: assessing the effect of arbitrary cutoffs of propensity scores.","doi":"10.5351/CSAM.2016.23.1.001"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2011,"outCitations":[],"journalName":"Journal of biopharmaceutical statistics","paperAbstract":"We consider analysis of two identical pivotal trials with correlated multiple hypotheses evaluated by the fixed-sequence, weighted Holm, or fallback procedure. For approval, at least one hypothesis must be rejected in both studies. Various weights are considered for the fallback and weighted Holm procedure to provide separation in a single study. Evaluation of the procedures as closed tests distinguishes which has the highest power in different situations. No procedure is universally optimal. The best procedure depends on the power to reject the various hypotheses, something that is never known with certainty, and the goals of the analyses. If the most important goal is to demonstrate a difference on the first hypothesis or on all hypotheses, the fixed-sequence procedure performs best. However, the fixed sequence often has the highest chance of obtaining inconsistent results between the two independent studies, which makes it less appealing. The weighted Holm and fallback procedures are very similar, with various weighting schemes providing modest differentiation. The alpha exhaustive version of the fallback procedure often has higher power for some endpoints and lower power for other endpoints compared to the weighted Holm procedure, but the differences are rarely large.","inCitations":["f3da1413a7101395d71f24c02d54ba1e78b0a254","9ddc221865f1dd90ab38ab633228eb6d2703679b"],"title":"Multiple testing procedures in two pivotal clinical trials for approval of a new pharmaceutical product.","doi":"10.1080/10543406.2011.551330"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":2016,"outCitations":["fe082a4de928884ec113cb093a1dc1e5e0ff08f1","540bc74ce2ddee234909f1dc7cb3d53cb03afe72","b3325f9be0df6ac33e1036e2c409d7ee29ab0c69","740618e2fa58412276a1c76c1e8e86920376f5e8"],"journalName":"Pharmaceutical statistics","paperAbstract":"A sample size justification is a vital part of any investigation. However, estimating the number of participants required to give meaningful results is not always straightforward. A number of components are required to facilitate a suitable sample size calculation. In this paper, the steps for conducting sample size calculations for superiority trials are summarised. Practical advice and examples are provided illustrating how to carry out the calculations by hand and using the app SampSize.","inCitations":["525038891b0e81a628c3b58be1a12a408e558bae","090a699485f216815e3f8792ddf627b5f817f8e6","f82273c8d234dcc9ff0e8b50beda879558ef199b","162928d7a6f4aadb7259fafd4a0876951df4bc1e","74f0c5bd1c9d2166193bba9bf1004e57c799cc39","dc9507f2f65ae1958709be6f090f653e29d8f150"],"title":"Practical guide to sample size calculations: superiority trials.","doi":"10.1002/pst.1718"}
{"fieldsOfStudy":["Economics","Medicine"],"year":2012,"outCitations":[],"journalName":"Journal of business & economic statistics : a publication of the American Statistical Association","paperAbstract":"Survey data on earnings tend to contain measurement error. Administrative data are superior in principle, but they are worthless in case of a mismatch. We develop methods for prediction in mixture factor analysis models that combine both data sources to arrive at a single earnings figure. We apply the methods to a Swedish data set. Our results show that register earnings data perform poorly if there is a (small) probability of a mismatch. Survey earnings data are more reliable, despite their measurement error. Predictors that combine both and take conditional class probabilities into account outperform all other predictors.","inCitations":["a069be42cdb16afcae648a1f399a28a6a8886f51","3af10e9bf5c99ec8331462a3d10480504d63d737","f6ad72f859b16a9776f3710d5d2a8da389ec46a9","4f183466ef6566cbec9b579aed0ce0e66c53ee55","008cc7347a49a03cd5073726e4acfc48f716a63d","000b1671fb47b42f0c2e72097230fce6de82be5d","2c9d4e6809b93fe12d470119f8ae114764a225a4","e9cef0f590af93259fa83e2c610579901eb248d7","a4e01bc60f3fc0a833a1482216278cdc57675ae7","e3c6ac300dfd87b6400ab9a4e96050fcf81ebf45","bc432b9fd6975d8b65c5ede419df37992da6f09d","bff4907bceeff42e0875e50a031cdd9d55eaefb1","b59a36bcbcd42629b2609cfda1f04f1215964716"],"title":"Measurement error in earnings data: Using a mixture model approach to combine survey and register data.","doi":"10.1198/jbes.2011.08166"}
{"fieldsOfStudy":["Medicine","Computer Science","Mathematics"],"year":2009,"outCitations":[],"journalName":"Technometrics : a journal of statistics for the physical, chemical, and engineering sciences","paperAbstract":"Tuning and calibration are processes for improving the representativeness of a computer simulation code to a physical phenomenon. This article introduces a statistical methodology for simultaneously determining tuning and calibration parameters in settings where data are available from a computer code and the associated physical experiment. Tuning parameters are set by minimizing a discrepancy measure while the distribution of the calibration parameters are determined based on a hierarchical Bayesian model. The proposed Bayesian model views the output as a realization of a Gaussian stochastic process with hyperpriors. Draws from the resulting posterior distribution are obtained by the Markov chain Monte Carlo simulation. Our methodology is compared with an alternative approach in examples and is illustrated in a biomechanical engineering application. Supplemental materials, including the software and a user manual, are available online and can be requested from the first author.","inCitations":["428ae5b6ca0c07aa72ceda0ce89035a609ef7fef","f5d3fb3a07a1ac87eff3d9d51f15f4dc33463901","c33150d90370b5c1cbfbc65cde1394ab288ce7cf","2f7ce63f71af9ad8d77506666008bec818c737a8","9a5f3c9fe0edf3fb12da4b45a6a8e8d998b9b5ce","a5ac99a178215821f80a17478207b1ba38923fac","67e4d0e24883c1c2bcd6db8d587e1d69acbdec5c","a4ad06996943bca6ace123275b8cd4237685eece","2bdeb5d75b316d99838f8fbb7b077e89b67c14c2","2385231b480b635d23bee8272e61a29d5d21da8c","26d8974ebb639d02776a6bce7569cb1b5b194415","4749472d466fecf8a58a2c978abdd3c7aa7f7b1b","0fd1d346d81a34e5cfa6ca973674019bf9fa5ff0","c36a658c3caeff96b5d598235be97b6a18eb3059","2c456345cb6cdb5c289345d0eb0e628c30a19fcb","f2ca9f1d629cb00b6f91ac5f8a417fd07833bf08","7fff2dfc60735a65e068693a929b04db39ec06cb","3733707cae81a1f535e39ab1625ea7d6502c5386","32218b31a05c87f1f9419e2de7adc12bf48c3f2c","ae65724023b1ff08b742d16b1c139a95cbfd5bb0","7e1b664b5f19dfca7631864cbf9a7ed459126391","fadcdbab8ceef0273f9d06023358610fec8c560e","27c02d9469d13896a5bd10887809e6b66a5c6ede","3928fe00907ce87d16cd18e7be2ff88388c3d38c","7d3927259a8a251916a9e3adc406accc03e730de","935089768f72f0e1e30650619a395ace3a574b9c","bc85057563cc57adc244e235d8de6d1909985c17"],"title":"Simultaneous Determination of Tuning and Calibration Parameters for Computer Experiments","doi":"10.1198/TECH.2009.08126"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2011,"outCitations":[],"journalName":"Statistics & probability letters","paperAbstract":"It is increasingly common to be faced with longitudinal or multi-level data sets that have large numbers of predictors and/or a large sample size. Current methods of fitting and inference for mixed effects models tend to perform poorly in such settings. When there are many variables, it is appealing to allow uncertainty in subset selection and to obtain a sparse characterization of the data. Bayesian methods are available to address these goals using Markov chain Monte Carlo (MCMC), but MCMC is very computationally expensive and can be infeasible in large p and/or large n problems. As a fast approximate Bayes solution, we recommend a novel approximation to the posterior relying on variational methods. Variational methods are used to approximate the posterior of the parameters in a decomposition of the variance components, with priors chosen to obtain a sparse solution that allows selection of random effects. The method is evaluated through a simulation study, and applied to an epidemiological application.","inCitations":["81a2fee62bcfba6bed7896780f554e95007d47e9","4b8d6bb9eb2457ddd85b6e32c6c6f3e2fe9f6a69","25184e0a832be1752394a557a76ecfeb55849c3c","6f24d7a6e1c88828e18d16c6db20f5329f6a6827","cbcf947a06b796a772206571ebd05cd61714da0a"],"title":"Sparse Variational Analysis of Linear Mixed Models for Large Data Sets.","doi":"10.1016/j.spl.2011.02.029"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":2018,"outCitations":[],"journalName":"Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America","paperAbstract":"We present an ensemble tree-based algorithm for variable selection in high dimensional datasets, in settings where a time-to-event outcome is observed with error. The proposed methods are motivated by self-reported outcomes collected in large-scale epidemiologic studies, such as the Women's Health Initiative. The proposed methods equally apply to imperfect outcomes that arise in other settings such as data extracted from electronic medical records. To evaluate the performance of our proposed algorithm, we present results from simulation studies, considering both continuous and categorical covariates. We illustrate this approach to discover single nucleotide polymorphisms that are associated with incident Type II diabetes in the Women's Health Initiative. A freely available R package icRSF (R Core Team, 2018; Xu et al., 2018) has been developed to implement the proposed methods.","inCitations":["aa606d3f51f533aa1033974ee550621acddf44a0","4ab3e04fc945563c98d7b9a408263146fc542a28"],"title":"A Modified Random Survival Forests Algorithm for High Dimensional Predictors and Self-Reported Outcomes.","doi":"10.1080/10618600.2018.1474115"}
{"fieldsOfStudy":["Computer Science","Medicine"],"year":2009,"outCitations":["9df2e3fcbcb8318a88423728a55bc8d35c7b58b3","c2d0bade0cae44f5aea50a56f937fe2876dad5d4","28a100644e4adc037dd09cfb9d1552a2bd76380e","f2ccc4718b4262ce55f650dc4cc789ad114ccf67","1f69fe8032f71afc88f6c57dfa2175b00ea92d3c","c993fd04b9df1f6cfdf43fddf0e3448fa49ed6e0","9445ef865c4eb1431f9cb2abdb5efc1c361172cc","1d5f09f3fc3bd91de52ba3168d6e7c72fa3cf560","ebc426cba4c95f4d264e817cb2874a27852a948d","3950ed4b3262d956134c46b915e68d341a6b5a29","cb8202c3189cce0908a721e59f049438db8654c2","e7f9254f8e9678dedd8c2ccee99624c271ceeb14","e1b086d541913a47fea50bccd9aacaddebb6d1c2","3d3c82d8989b0053da3fc7b0598cb72457442fd1","0427cdd54bb4c66c2cd78a7c69e92359a805a768","8f491657307dfc68c205979eb51b2ef63199cc15","d34a3fcdbd9c88434369e5d675bdbdd1fad7e816","dc56191c9fe295fcb5a05bcbeb495e7f827c09ce","dc1f22cfff1672cf000c48d47e2ce1cb1b25c660","a88799b6d2006aacf41a1f8afbb67df6c26b2d42","ca4e9741e19ac47503b28438671366dba43ce8d6","377339cd55087d503b855ae89d2126495cf104ee","380f7bf31b898ace68caa597340e39e65926a87e","e45b74bf3ede47ff25dee775800d16cfdf01cfdc","da6f3e9c79e908e70e23684e2b6f26c59ad4810e","a7b6fbfe738a3b285ed758082e50275325e7d12e","7ca1a6d9938ff78365279c7824be9efc79caebf6"],"journalName":"Computational statistics & data analysis","paperAbstract":"Bayesian models are increasingly used to analyze complex multivariate outcome data. However, diagnostics for such models have not been well-developed. We present a diagnostic method of evaluating the fit of Bayesian models for multivariate data based on posterior predictive model checking (PPMC), a technique in which observed data are compared to replicated data generated from model predictions. Most previous work on PPMC has focused on the use of test quantities that are scalar summaries of the data and parameters. However, scalar summaries are unlikely to capture the rich features of multivariate data. We introduce the use of dissimilarity measures for checking Bayesian models for multivariate outcome data. This method has the advantage of checking the fit of the model to the complete data vectors or vector summaries with reduced dimension, providing a comprehensive picture of model fit. An application with longitudinal binary data illustrates the methods.","inCitations":["a0186ee12e95b0ca773ac6ec493c0beeecce0263","602605f9e8de32a719f1e471083dd21ad276ad1f","ce1c3c5ff9ae2c18cf9cf17b1ef57fa0b2f7911c","04349780fd41409d423ab1aa2f454f3a8a938204","107ecf9aa48c8a3614eeb688d9ab19a2547b5dd2","0c2d407e75a7ea25c677e54168d85ac79997e9a0","5460eabd6725135c8d77d3f973168bf68e879fb5","387a8fb7d07d6f0d1e8d9c7e67432659505e907e"],"title":"Bayesian model checking for multivariate outcome data","doi":"10.1016/j.csda.2009.03.024"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":2014,"outCitations":["b0ebbcf713b3ddf3f94325bc58dc39ff76fdc412","e6ba45703e734f7c115d7a4322734b5e99eb8e70","a42a94a56e0aebbca0f2b087c125f24198b23ca9","edde8da3897e6e122216a7618837c8235aac8451","ab9733e328354a28beb09d93ec68c2c08e992217","d37ba4ab59f19003efa2668f702f4c1c215a5d61","8cbafca9a8053d1ef4838239f1d574813f4176af","2c72204ee7b57ec9f93cbac6bf53638c466e4bcc","9ac196c5e6951bf74a8db3b4f3eacfcec9104fdd","22f29d13de94ea0fed6a920f1f388c5b5158f09b","15f221e5cf032b0084ad1e61b47826211d51eb91","8526eeb33ce057908161216d184274b61e3d7858","af4b3d01c44d7a404f64aa6b8da49cdbc8cb0759","95b4fe7aa4a1846139bc748e53ea769225b278b4","ec7989e35374c2300fd38e3237510f8e2bd3dc72","c023c14fbd797745d7c075688c618b93a7349aa9","67371563920b834061478a8435def96cd2e9af63","b5c522f260f8f6b671bed73a115efc2b8cf28063","73d94e35dd554ecb2b5e2cc14f45f4324b3496e9","5ef1b4f5c7bd9a116e99f7f1eda4527449a6482b","f4890345d1f0547606508185cf65d49613fbd423","5ee21e28b4c4f2b81fb06461559e5c9d52a1f541","66e908ecf77d4e7e72887d35adccd801f24e55fd","7aa8ab130b923eb71295dac6303239dceb7301fe","51ab57cdf693b00e812994522745587af3e2cc50"],"journalName":"The International Journal of Biostatistics","paperAbstract":"Abstract This article describes an extension of multiple contrast tests to the case of multiple, correlated endpoints. These endpoints are assumed to be normally distributed with different scales and variances. Unlike in previous articles, the covariance matrices are also assumed to be unequal for the treatment groups. Approximate multivariate t-distributions are used to obtain multiplicity-adjusted p-values and quantiles for test decisions or simultaneous confidence intervals. Simulation results show that this approach controls the family-wise error type I over both the comparisons and the endpoints in an admissible range. The approach will be applied to a semi-synthetic example data set of a randomized, placebo-controlled phase IIb dose-finding study of a novel anti-muscarinic agent for five continuous endpoints. A related R package is available.","inCitations":["3abd58aababcdbe732430b65ca06c7d899cdd54c","2d0ad5920aa656102f72d92139319a8c798b58ff","fdb0331482e1de3359ee91d144c008294f271fd6","373a0cd7973ef82407f5a23c01cf9d7471296d78","9c50a9ba3965142a71d4d8ded61de636a7669128","1f6db6e487153886aa5cec1e0efd2b30bac441b3","fcdfd757451f850aec23f5047527082344911b3a","d2020ffd5a6b0c9aadb9ad4db47a897a743337ab","68f1037c712b3a9814a80443e095cf55670aa669"],"title":"Multiple Contrast Tests for Multiple Endpoints in the Presence of Heteroscedasticity","doi":"10.1515/ijb-2012-0015"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2005,"outCitations":["5b0e081ca36e980b7feed0c9f6de317ab58f15d1","dc45f718f4345396933c7066f82247eb400b970c","548dc14df3ab48927f24303d2a7c88a9d29ba9a6","aa33f4ec1d444027973bc4ad50a8d4e8b1f76148","173032b06eaae51616b66a06d7858cc44872fcab","dc13855d4239d7e2bb589ba3e6b48d223685c58a","d1396cf642f19aae90cc5bed217308350ca08367","3707330e91c8a164ef398605f3e9d57f221db889","83dc2fe1109b0387642db96ddf01766d0c814f28","1ec8e599d8d44c3b079182a4d7dffd062a8cb1dc","68c9890df768d348ef10e57f825dd25f7b2ac0f4","5f7a9605ee6b5cc9ba0cdf2735a7c3e77d188471","fab4dc887d0add769f54e6b1c53c8e40632605e5","cb619bb8dcd4aae3b3ff8acc0eea191afbc1af65","b38a9ecb058c361ae34f31379044cd94ef31367f","b4de2c0c85c43ff9075f6eb2d247bbdaddcbdb58","0b3bf78d63374eec590204de72d36aa75722278d","8cecb8c9effa4e0b0a3985ccde57a7b460023aa6","25bb47eaa5d3104f74be57bc6bc83376e49fdb1e","29c4d97db441ff36e7ebd84cf4994a26a1adae04","ec0d4b872a61c75d66c6625c4a2eeeb722af3b8e","266a32615cdc2028eb743dc19d28242c8e67e357","cd082453eb46f3f37d758ce40a5c0e334092d475","c3ce69a2dbb178fa14b4201c8364960f23fd56c6","bcf16685fb1a401dbbbe2892af251cc887baacd4","78e404e6acea49ade49a58ba173f9ea5cc85e83d","d751b833935621b54d69c48a6f918839f9d1473f"],"journalName":"Biostatistics","paperAbstract":"In the research of public health, psychology, and social sciences, many research questions investigate the relationship between a categorical outcome variable and continuous predictor variables. The focus of this paper is to develop a model to build this relationship when both the categorical outcome and the predictor variables are latent (i.e. not observable directly). This model extends the latent class regression model so that it can include regression on latent predictors. Maximum likelihood estimation is used and two numerical methods for performing it are described: the Monte Carlo expectation and maximization algorithm and Gaussian quadrature followed by quasi-Newton algorithm. A simulation study is carried out to examine the behavior of the model under different scenarios. A data example involving adolescent health is used for demonstration where the latent classes of eating disorders risk are predicted by the latent factor body satisfaction.","inCitations":["ecd696e0a2abccd256478fc766c2dbbce118a398","e3fe91c4b1e68895543eeb289f8ffc924851ffc8","a7aa0291a39c15082aadfa000e5a6234e852c38f","e38f89db7066bc0ea4a9d2c3eff73d7f6effdc5b","2b4c4836f89ed4bde4cb19737a0bc38c72facc93","fe2696f85cc633ca73601e94fa74dad9d7d6bba6","31f43ac6a790fd538f1c93b444a1919d32aa81ef","4f76250fb7df49e04c39f5f0122e5b801097921e","44a9693259a566a5f6be6319a1f9c464385bc95b","2633a0093205483f00a8072ea84c0d1fbb182982","9d00e75aa44e0d591af2c93e0ffd5451c6f83235","7ab386f90315175960f84c10d434e4c09bf39be1","e572aecf4ab4dbfc433145512205c8889c4ecc06","e940f50d2a9d89963b3ecb66d57e4022720f165f","e010b45acf75c0d5ba95d81ba59110f34a3b06a1","127c44dbc1fd606de08d5cf10bb9532408648f60","0dc7d0f6ce0a6aabfa7e86e069117c6b67184a39","e4ba77bf644d9ba9c05a603a8c9ba86636fc8a64","209e7c4743258710ef6e9537f1ce8eb7b7091b2f","8cc8513ff40bd7fbc94dd2fb9c0cb843f0d71e14"],"title":"Latent class regression on latent factors.","doi":"10.1093/biostatistics/kxi046"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2004,"outCitations":[],"journalName":"The British journal of mathematical and statistical psychology","paperAbstract":"Clustered ordinal responses, which are commonplace in behavioural and educational research, are often analysed using mixed-effects ordinal probit models. Likelihood-based inference for these models can be computationally burdensome, and may compromise the consistency of estimators if the model is misspecified. We propose an alternative inferential approach based on generalized estimating equations. We show that systems of estimating equations can be specified for mixed-effects ordinal probit models that avoid the potentially heavy computational demands of maximum likelihood estimation, and can also provide inferences that are robust with respect to some forms of model misspecification--particularly serial effects in longitudinal data.","inCitations":["dee9137311589d42759d956f1d711ff2eb8f323e","0b1ef8f466300b0756e4002196658eaaa87bb1e0","5c365a798186881d651477209f7919215588aadf"],"title":"A generalized estimating equations approach to mixed-effects ordinal probit models.","doi":"10.1348/0007110042307177"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":1998,"outCitations":[],"journalName":"Journal of biopharmaceutical statistics","paperAbstract":"McNemar's test is used to test the hypothesis that one treatment is better than another in a matched-pair design for binary outcomes. The conditional binomial test in such a matched-pair design is the exact McNemar test. However, in many clinical trials, one wants to establish equivalency between two treatments. We discuss how to use a conditional binomial test to establish equivalency between two treatments in a matched-pair design. Sample size and power determination for each conditional binomial test are calculated. Some statistical properties of the tests are analyzed through Monte Carlo simulation.","inCitations":["45b35d60fda0d2f5e7fbc2c9b342a8cb546edbc5"],"title":"The conditional binomial test revisited for clinical trials.","doi":"10.1080/10543409808835258"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":2014,"outCitations":[],"journalName":"Scandinavian journal of statistics, theory and applications","paperAbstract":"In this paper we propose a general class of gamma frailty transformation models for multivariate survival data. The transformation class includes the commonly used proportional hazards and proportional odds models. The proposed class also includes a family of cure rate models. Under an improper prior for the parameters, we establish propriety of the posterior distribution. A novel Gibbs sampling algorithm is developed for sampling from the observed data posterior distribution. A simulation study is conducted to examine the properties of the proposed methodology. An application to a data set from a cord blood transplantation study is also reported.","inCitations":["00e7a0b907f6fcc44faa3f2bc690e7f2a91799e7","341ca1161457ca4a5854c2725a731a4ed825ce8e"],"title":"Bayesian Transformation Models for Multivariate Survival Data.","doi":"10.1111/sjos.12010"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":2015,"outCitations":["c16093341a78fdbec9238e49bcd717b7cf2c9de6","7b12335d764afd0f9c2e762301c8fd62e8763a0b","9de30a72015f64e3a830446ef7bae72d72d1d859","eeaa179e578c249609a40fc727b5e34986e51456","1d09d3858a1a6faf0fd8e47955d7631e53cb7e48","ab8ff2b08acb1e673fd0c6fabea46d60db5031b4","1ab838530d255c8c854b4315a51d9437d26121b0","0fb3827eba0a3f67c007298eda0f70e10f6556c1","1b254dbc7081efb18e36ebdd28fd04471e2ce775","91b9fcff542b4e3dab7ed033ea6bfddee521bc35","bb88d12e9103fa92e4b7298f85f3822337e88463","ad3c8e8c3cc181d84bbe32d9bc460ac128222b71","09e23df2079c4a575e11729c1dad046463c58b05","646a54787238a8b10728e4567a679be9649253ed","4a6fead01c405876cb4045e16c973a73b2c4328e","c604566cbe07c1db88b8e4d095abe885aabcd313","a4d9fe16746accd6f0c732f8254a0c0e61c43401","3a2f3fb5adc4a6d3b2daf6f4f20a808fa1b5a961","10d5f67a88dd4acb2e5b493116100e48504e08b0","5840511c7bc264e07f2bdc27317bb37f5bc7d871","4717c0a4e4be56a46ca423015ef9712679b66be0","cb8202c3189cce0908a721e59f049438db8654c2","cec775be96a4cedc1982a58ff1b3b07cf33aa214","b457820831cafc3b7106b4fad596f8a7a70d58ea","e247acaf3d055824b18c0c3be08e3adec16034ea","502fdc27403970457b51007726ff4db10b4525d1","f31c2ddb7bb3f3f6ef4219143901cc0cddca5968","120d904f31046eab647448fd0db491002941680a","885bd258bc8f5d3651345f57de87236160095d6f","44ccb2c8373238184bb9c04bef0219606ecfe6c8","a91c1afc7b1d813cb3662c7e1f4dd0fafb524da4","65b2633674e69591c5ad4490de6f835f60765de9","ccb89d766b48615aaf146f97e1da9aca4ed174cc","b4b3d39dd7be4a1bed4b3f6694552899256ecf66","e8acf0662ca9547316200992e35f42922787683e","0bf2a11aff6ff773c5fa9ecc07c141bf026612e9","a496cc7b6b5163772b07fc242bbf0319cfb56b5e","6688aaccc1ff4fc709ea05356529f70d98c4b457","bb499a1a17ea8cfd77a62db558ef433db4071103"],"journalName":"The annals of applied statistics","paperAbstract":"Understanding the factors that explain differences in survival times is an important issue for establishing policies to improve national health systems. Motivated by breast cancer data arising from the Surveillance Epidemiology and End Results program, we propose a covariate-adjusted proportional hazards frailty model for the analysis of clustered right-censored data. Rather than incorporating exchangeable frailties in the linear predictor of commonly-used survival models, we allow the frailty distribution to flexibly change with both continuous and categorical cluster-level covariates and model them using a dependent Bayesian nonparametric model. The resulting process is flexible and easy to fit using an existing R package. The application of the model to our motivating example showed that, contrary to intuition, those diagnosed during a period of time in the 1990s in more rural and less affluent Iowan counties survived breast cancer better. Additional analyses showed the opposite trend for earlier time windows. We conjecture that this anomaly has to be due to increased hormone replacement therapy treatments prescribed to more urban and affluent subpopulations.","inCitations":["b038b4e73ce901a187899282d914f6eab717f96f","ce5c2d2e4be2307db89d2974727f8013bb77296d","a956f9c0ef556506f23cb8f0eba811581eee1335","d1ed9b84ea5e0e8b184607a4c4f242c679027041","2197bc37065e1b8ac0bd4bb1185109dfb08ac5f0","d9527fe4b481ad1d5979451c46ff3645783ff18d"],"title":"Modelling County Level Breast Cancer Survival Data Using a Covariate-adjusted Frailty Proportional Hazards Model.","doi":"10.1214/14-AOAS793"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2015,"outCitations":[],"journalName":"Biostatistics","paperAbstract":"Modeling correlation structures is a challenge in bioinformatics, especially when dealing with high throughput genomic data. A compound hierarchical correlated beta mixture (CBM) with an exchangeable correlation structure is proposed to cluster genetic vectors into mixture components. The correlation coefficient, [Formula: see text], is homogenous within a mixture component and heterogeneous between mixture components. A random CBM with [Formula: see text] brings more flexibility in explaining correlation variations among genetic variables. Expectation-Maximization (EM) algorithm and Stochastic Expectation-Maximization (SEM) algorithm are used to estimate parameters of CBM. The number of mixture components can be determined using model selection criteria such as AIC, BIC and ICL-BIC. Extensive simulation studies were conducted to compare EM, SEM and model selection criteria. Simulation results suggest that CBM outperforms the traditional beta mixture model with lower estimation bias and higher classification accuracy. The proposed method is applied to cluster transcription factor-DNA binding probability in mouse genome data generated by Lahdesmaki and others (2008, Probabilistic inference of transcription factor binding from multiple data sources. PLoS One, 3: , e1820). The results reveal distinct clusters of transcription factors when binding to promoter regions of genes in JAK-STAT, MAPK and other two pathways.","inCitations":["217f32d8f973e2a1e364507a4ff01ceb1da89a34"],"title":"Compound hierarchical correlated beta mixture with an application to cluster mouse transcription factor DNA binding data.","doi":"10.1093/biostatistics/kxv016"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2003,"outCitations":[],"journalName":"Journal of biopharmaceutical statistics","paperAbstract":"Subgroup analyses are quite common in clinical trials although the subgroup findings are usually presented without adjustment for the multiple analyses, which increases the chance of false positive findings. This paper is focused on the multiplicity aspects of subgroup analyses in multiarmed randomized clinical trials and provides some guidance to practitioners.","inCitations":["d437051d93b2cc5820529ea7bfc9b9fe1ccaaa4c","b2af5cb367cd5923ee94c37b0700d549e3e30237"],"title":"Protocol designed subgroup analyses in multiarmed clinical trials: multiplicity aspects.","doi":"10.1081/BIP-120024201"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2013,"outCitations":[],"journalName":"Pharmaceutical statistics","paperAbstract":"Interpreting data and communicating effectively through graphs and tables are requisite skills for statisticians and non-statisticians in the pharmaceutical industry. However, the quality of visual displays of data in the medical and pharmaceutical literature and at scientific conferences is severely lacking. We describe an interactive, workshop-driven, 2-day short course that we constructed for pharmaceutical research personnel to learn these skills. The examples in the course and the workshop datasets source from our professional experiences, the scientific literature, and the mass media. During the course, the participants are exposed to and gain hands-on experience with the principles of visual and graphical perception, design, and construction of both graphic and tabular displays of quantitative and qualitative information. After completing the course, with a critical eye, the participants are able to construct, revise, critique, and interpret graphic and tabular displays according to an extensive set of guidelines.","inCitations":["5053b1f20f57797dfecc5e6637cca7bcada72af6","301b149f2958ef0531c9ab7b91acc9d04277aff2"],"title":"A course in constructing effective displays of data for pharmaceutical research personnel.","doi":"10.1002/pst.1563"}
{"fieldsOfStudy":["Mathematics","Medicine"],"year":1996,"outCitations":[],"journalName":"The British journal of mathematical and statistical psychology","paperAbstract":"When an individual is engaged in sampling from a finite population, an assessment of their working memory for previously sampled objects is often desired. An extension of the classical occupancy distribution provides a framework for testing hypotheses about working memory capacity, based on a general model of working memory in which the individual retains a record of m previous inspections (and hence does not make the mistake of resampling these objects) and samples with replacement objects outside the current memory set. The buffer size m provides a common metric for assessing the effect of variables on performance in search tasks involving different numbers of items, or locations.","inCitations":["dd5129d1a0607d3e52ab3690e7b3e4b3cd0cfc55"],"title":"Testing hypotheses about working memory capacity.","doi":"10.1111/j.2044-8317.1996.tb01087.x"}
{"fieldsOfStudy":["Medicine","Mathematics"],"year":2015,"outCitations":["e3e9a1999f6be3cf7fef9a76e0b0819cef88ecae","c5be3938017da8f264a1eba31201fc797822b54c","63f34da025bb35617133777ddfcd3e590730291e","27f33f0773cb59248068bd1276689047ed00d135","7b0dd56eb6b0711e11c65895b4ce4cb987b2dd15","cf84b85711459d93dff889251e74030825e96c05","32b6f87dae6c8f96dd885857a154ca8a200bea53","9d59e5c5d029345e176da0351a0831b9cf762096","d182dc7da5991d98e7e633e30724f20bc7a5a21c","fa0f05b6c48120083dd4cc07b85fe22a2e8f6030","9735373d5d1be78390e08decdd7c618a665ea77b","0f407a945f7c4bfa2f7b0639da194ec8ea435318","80e111641493c2f96c6989f1b60c9b67105aefb9","7a4bfff10af970bdb4e51232cc45decfaba2d725","b447803045664f34a1bbfa189148ce31912e0ba8","e3aecdbaba0f11fc7b5bfc097b82ca555fb1e785","36bd754bda97425b54424bbb42bcfaed918e4114","a1b67f32bc06a30a93d7b400ea5aa9cb9616949f","a69cdc411ad57393a580581f549af6b91be4ad68","d6c20c655098619c1845076045601c6e9fab1c29","c0d78ad466ae9cf3a9b867128f934e086f0643f7","96a9fd54ca810a8691026a3717b449bffd10cd2f","97a9b427c5ea491047ea7c475740e5ed9ca6acbc","f666520e0c2bfaf15ab305fa59853e444da83799","620e5f5e74453fb419e2f9cdc8d25b491cf87cd1","234497ff4a32a3d749844e815d41ae98afa51225"],"journalName":"Journal of biopharmaceutical statistics","paperAbstract":"Clinical trials often use a binary \"fold increase\" endpoint defined according to the ratio of interval-censored measurement at end-of-study to that at baseline. We propose a simple yet principled analytic approach based on the linear mixed-effects model for interval-censored data for the analysis of such paired measurements. Having estimated the model parameters, the risk ratio can be estimated by explicit composite estimand and the variance is estimated using the delta method. The estimation can be implemented using the existing procedures in popular statistical software. We use antibody data from the Chloroquine for Influenza Prevention Trial for illustration.","inCitations":["f8357308ee70115eef4eb8785b5192f99e35723c"],"title":"A simple and powerful method for the estimation of intervention effects on serological endpoints using paired interval-censored data.","doi":"10.1080/10543406.2014.919936"}
{"fieldsOfStudy":["Mathematics","Medicine"],"outCitations":["f2f192cf5412ad21b193a25b417413ec88e45234","4329dec664f4a3f5c02ad7def18634f14e1681c1","527e7c2918e68b95f7db77c99085a60977e343e1"],"journalName":"Biostatistics","paperAbstract":"Unlike majority of current statistical models and methods focusing on mean response for highly skewed longitudinal data, we present a novel model for such data accommodating a partially linear median regression function, a skewed error distribution and within subject association structures. We provide theoretical justifications for our methods including asymptotic properties of the posterior and associated semiparametric Bayesian estimators. We also provide simulation studies to investigate the finite sample properties of our methods. Several advantages of our method compared with existing methods are demonstrated via analysis of a cardiotoxicity study of children of HIV-infected mothers.","inCitations":["a7d632902364b36970df21738ecacc100afaffb1","1479c7177d384ac500477cd2c869cafd8df97b07","15a9365a14989005432ff8e243ce7b8576a8a8b7","3931f8f976d8a0d7389c3f691ca275a869e8125d"],"title":"Bayesian partial linear model for skewed longitudinal data.","doi":"10.1093/biostatistics/kxv005","year":2015}
{"fieldsOfStudy":["Mathematics","Medicine"],"outCitations":[],"journalName":"Pharmaceutical statistics","paperAbstract":"We consider the blinded sample size re-estimation based on the simple one-sample variance estimator at an interim analysis. We characterize the exact distribution of the standard two-sample t-test statistic at the final analysis. We describe a simulation algorithm for the evaluation of the probability of rejecting the null hypothesis at given treatment effect. We compare the blinded sample size re-estimation method with two unblinded methods with respect to the empirical type¬†I error, the empirical power, and the empirical distribution of the standard deviation estimator and final sample size. We characterize the type¬†I error inflation across the range of standardized non-inferiority margin for non-inferiority trials, and derive the adjusted significance level to ensure type¬†I error control for given sample size of the internal pilot study. We show that the adjusted significance level increases as the sample size of the internal pilot study increases. Copyright ¬© 2016 John Wiley & Sons, Ltd.","inCitations":["c16212d71b03da91f1ec79cecf4a1e760387fa5c","7283608b9b354c36fa3e2535df5de8dca4921357","a08a713c359970f218dd4916767c7f54721dbc5d","fe33fa77a0cf3a9cc99a0681db97bce97786dec0","eaf6cee68a06d219e0559209082654f714d9cb66","29091d66b9d54492e1b01c275e9f57b3f56b07c1"],"title":"Distribution of the two-sample t-test statistic following blinded sample size re-estimation.","doi":"10.1002/pst.1737","year":2016}
{"fieldsOfStudy":["Computer Science","Medicine","Mathematics"],"outCitations":["be8a0ffbda6b3dd8c1a1057d530d17003bc58c6c","41c6f229c4b149d502f89ffc386febb24116bd25","3e59ebb37013a296753cbea33eacd6416f0ff6a4","272503d42d96b3623c0430975b61b26ce8677068","5c28b24b0ecb610c6a527b32c3acb2c03b1bc184","a4e7cd2c59d72d1900b8994bf22f61316a4fef87","9ddd67d022f4fd293565f811c5d373626988ce88","98c76e2a9b42e20a596152f5aa12c1c97b9963d0","b16cd25aef1d6663167733a2ac7681a8d7b23990","8cf5c602f55461340860a37678d99ac72b2c1762","038c9c9b8079ed418005a352d8087fe614fb68f2","d75052634fe13c350a72c1fc388c8b95296dd9fb","9b8385a88c93750aa79ee07c631d138794c82c5c","d2dfbcc1423207f4f44cb1c5b7dad65a381a7045","156e7730b8ba8a08ec97eb6c2eaaf2124ed0ce6e","e7b9bb433eb30eae9bbec7d4ae97903a6718c083","f3bd9daa85d0c92aebeff81189cd6c29e1c50c2e","014bb1d12e0637dd1c92d34a047054de293f584a","9c6ad153f9946cc6279204782e1998a040839d57","1fd7be95b333ad74f105a03de7d6ae741fca4c4d","fcef2258a963f3d3984a486185ddc4349c43aa35","e898ba167b202c8a1d78226a0f8d8c29cd273bd2","7d996ae76798cc9e39dfb7d024f4b08e4b17b3f5","d42337ecab378287fbcd60b42e5ceb5b67b6f59a","3a17ea0ab03b7939d1f80b152abab71a3c1fd1ed"],"journalName":"Computational statistics & data analysis","paperAbstract":"When analyzing high-throughput genomic data, the multiple comparison problem is most often addressed through estimation of the false discovery rate (FDR), using methods such as the Benjamini & Hochberg, Benjamini & Yekutieli, the q-value method, or in controlling the family-wise error rate (FWER) using Holm's step down method. To date, research studies that have compared various FDR/FWER methodologies have made use of limited simulation studies and/or have applied the methods to one or more microarray gene expression dataset(s). However, for microarray datasets the veracity of each null hypothesis tested is unknown so that an objective evaluation of performance cannot be rendered for application data. Due to the role of methylation in X-chromosome inactivation, we postulate that high-throughput methylation datasets may provide an appropriate forum for assessing the performance of commonly used FDR methodologies. These datasets preserve the complex correlation structure between probes, offering an advantage over simulated datasets. Using several methylation datasets, commonly used FDR methods including the q-value, Benjamini & Hochberg, and Benjamini & Yekutieli procedures as well as Holm's step down method were applied to identify CpG sites that are differentially methylated when comparing healthy males to healthy females. The methods were compared with respect to their ability to identify CpG sites located on sex chromosomes as significant, by reporting the sensitivity, specificity, and observed FDR. These datasets are useful for characterizing the performance of multiple comparison procedures, and may find further utility in other tasks such as comparing variable selection capabilities of classification methods and evaluating the performance of meta-analytic methods for microarray data.","inCitations":["c5e831f48aba75772cafb45db48d5bef49bfa6a2","71e8e17f265ee74c1f9b95c21ee7d6b5bd1a4791","e96df9458b2bd0fa25e6e6fa44194975752d4b79","2175d667fbfb171c50cd37f0fd5e34d3b6f91dea","7809664799f01b300241ac9239057a883e81670d","a0d32e76e1b394f985c139132edc4aaddf9f8dbf","3461cb8ffc7c6ed7796cb9828f71e6f5aba607f2","f626d4d1c17b35a18284ad015afb3f96d20b4fd8","b2193459844f907e321909cbbd9fe8e8ea3c7754","3d6badab86e3d430c8e61ac1b38640e691e42170"],"title":"High-throughput DNA methylation datasets for evaluating false discovery rate methodologies","doi":"10.1016/j.csda.2011.10.020","year":2012}
{"fieldsOfStudy":["Mathematics","Medicine"],"outCitations":["2a2dd52914a3b7ba0bfa6443d3398e00db7012bd","778e527694ca4b92638b1ae4b166ccbf52aff981","c52596526e0aca84d41e0ba8817161474c85ce32","62d6fd8a9ee0af5b220726c84a332e96a22aa4e4","5d6092c6e5f3521e1e10358850bdb225bac100a1","6c0d1c7cdb9fa85c388aa4b6870760d9310e599d","5b7942450161d6d1f9dc88f1e4dfafdd6aa5fd0b","3c7f619a792b2f1863ce936fda65f5fec22d1a8e","0217749c951d8cff01393f9d67e7c7f0ea7ed156","308ccf27077967f8cd767923935135c8209aa737","819a9e12a28d01f9e961cd63aec877b59ffc1447","db88b01fbfd07b5cfb5deb1cee2eea4c10721387","34228138d5d5acefceb1c5fd4d31e8b92b2754da","32365cb6c53f3d0db6f9278fa1fbd0d883f4a4aa","a3138e388b8bd1aa9b29fbaa847a82e853af08db","817332171614d58816ef62b84e00b6db6181d644","8d73cb1dde9d31f22047df57de96e87f9d6bc424","017f55de79c1abb1224bd40f1001fbd79b446283","0aa17fa4a14894181a10219dc654bc9c09b5f34a","ca695cc71ea4b92b1816ae8704b50d6a1fdbf4ed","579d983dbc199218455248b7727ad7e325e09ce3","7743af78bb253594e4dde7e0ced27e3d5f6e1d87","8097dabebe3bf41349b5b6bcfd9ffa1f5322a3a7","7d81ada0f29d010cadf3a6cda5d1dafe23a9ccd3","3d5795c7648f5e6f89f519f51fa93e439ad7c890","c24e9b15cef07eefcc158b1356debe8ef0680c52","a4a1cf47f43a6dc520053846101648196d26f18b","857efbeb0094ed7dfc407f0156c9b90b6d6ca6a2","98d1abab0c5be31e3cc9b23d3c8825a533046add","8593210d3fade5211517628df5a386b1d451d2c9"],"journalName":"Journal of probability and statistics","paperAbstract":"A Bayesian adaptive design for dose finding of a combination of two drugs in cancer phase I clinical trials that takes into account patients heterogeneity thought to be related to treatment susceptibility is described. The estimation of the maximum tolerated dose (MTD) curves is a function of a baseline covariate using two cytotoxic agents. A logistic model is used to describe the relationship between the doses, baseline covariate, and the probability of dose limiting toxicity (DLT). Trial design proceeds by treating cohorts of two patients simultaneously using escalation with overdose control (EWOC), where at each stage of the trial, the next dose combination corresponds to the Œ± quantile of the current posterior distribution of the MTD of one of two agents at the current dose of the other agent and the next patient's baseline covariate value. The MTD curves are estimated as function of Bayes estimates of the model parameters at the end of trial. Average DLT, pointwise average bias, and percent of dose recommendation at dose combination neighborhoods around the true MTD are compared to the design that uses the covariate to the one that ignores the baseline characteristic. We also examine the performance of the approach under model misspecifications for the true dose-toxicity relationship. The methodology is further illustrated by the case of a pre-specified discrete set of dose combinations.","inCitations":["6b478146a1b8e4fe2474d69d278fdae5564cf0ec"],"title":"A Bayesian Adaptive Design in Cancer Phase I Trials using Dose Combinations in the Presence of a Baseline Covariate.","doi":"10.1155/2018/8654173","year":2018}
